Form 4: Atlassian CEO Michael Cannon-Brookes Executes Stock Sales Under 10b5-1 Trading Plan
SEC Form 4
Atlassian CEO Michael Cannon-Brookes sold shares of Class A Common Stock on April 10, 2025, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Michael Cannon-Brookes, CEO and Co-Founder of Atlassian, executed multiple sales of Class A Common Stock on April 10, 2025.
- These transactions were carried out under a pre-existing Rule 10b5-1 trading plan adopted on February 8, 2024.
- The sales were conducted at varying prices, with weighted-average prices ranging from $195.5011 to $203.5078 per share.
- A total of 7,848 shares were sold, resulting in a decrease in the number of shares indirectly beneficially owned by Cannon-Brookes through a trust.
- Following the reported transactions, Cannon-Brookes indirectly beneficially owns 309,972 to 316,720 shares through the Cannon-Brookes Head Trust.
Sentiment
Score: 6
Explanation: The document itself is neutral as it reports stock sales under a pre-arranged plan. The sentiment is slightly positive as the use of a 10b5-1 plan reduces concerns about insider trading, but the sales themselves could be interpreted as slightly negative.
Positives
- The sales were conducted under a pre-arranged 10b5-1 trading plan, which can mitigate concerns about insider trading.
Risks
- While the sales are under a 10b5-1 plan, large insider sales can sometimes be perceived negatively by the market.
Future Outlook
The document does not contain any specific forward-looking statements regarding the company's future performance.
Industry Context
Insider trading activity is always closely watched in the tech industry, especially for high-profile executives like Michael Cannon-Brookes. The use of a 10b5-1 plan is a common practice to avoid accusations of trading on non-public information.
Comparison to Industry Standards
- Many tech executives use 10b5-1 plans to manage their stock sales, including executives at companies like Microsoft, Apple, and Google.
- The volume of shares sold is relatively small compared to the total outstanding shares of Atlassian, suggesting it's likely part of a personal financial strategy rather than a reflection of concerns about the company's prospects.
Stakeholder Impact
- The stock sales could have a minor impact on shareholders if they interpret the sales negatively, although the 10b5-1 plan should mitigate these concerns.
Key Dates
| Date | Description |
|---|---|
| 2024-02-08 | Date the Rule 10b5-1 trading plan was adopted by the Reporting Person |
| 2025-04-10 | Date of the reported transactions (stock sales) |
| 2025-04-11 | Date of the signature on the Form 4 filing |
Keywords
Atlassian, Cannon-Brookes, insider trading, Form 4, stock sale, Rule 10b5-1, TEAM
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.